Newron Pharmaceuticals bags up to €38 million to fuel Phase III ENIGMA-TRS program
A final tranche of €12 million will follow, contingent on positive pivotal study results, with the share price calculated according to an agreed formula
A final tranche of €12 million will follow, contingent on positive pivotal study results, with the share price calculated according to an agreed formula
PreemieFort Enteral Solution's approval marks the first time a nutritional product derived from human milk has been recognized as a prescription medicine anywhere in the world
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
The new service delivers end-to-end support, managing every stage of an epigenomics project
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The applications aim to launch Phase Ib/II trials for relapsed/refractory multiple myeloma and primary plasma cell leukemia, respectively
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Subscribe To Our Newsletter & Stay Updated